Patent details

EP2771034 Title: TOPOISOMERASE-I AND-II INHIBITORS FOR USE IN THE TREATMENT OF PATIENTS SUFFERING FROM CANCER

Basic Information

Publication number:
EP2771034
PCT Application Number:
US2012061952
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127837839
PCT Publication Number:
WO2013063286
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TOPOISOMERASE-I AND-II INHIBITORS FOR USE IN THE TREATMENT OF PATIENTS SUFFERING FROM CANCER
French Title of Invention:
INHIBITEURS DE TOPOISOMERASE-I ET -II POUR UTILISATION DANS LE TRAITEMENT DE PATIENTS SOUFFRANT D'UN CANCER
German Title of Invention:
TOPOISOMERASE-I UND -II HEMMER ZUR ANWENDUNG BEI DER BEHANDLUNG VON KREBSPATIENTEN
SPC Number:

Dates

Filing date:
25/10/2012
Grant date:
08/08/2018
EP Publication Date:
03/09/2014
PCT Publication Date:
02/05/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/08/2018
EP B1 Publication Date:
08/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/10/2018
Expiration date:
25/10/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/08/2018
 
 

Name:
Nektar Therapeutics
Address:
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158, United States (US)

Inventor

1

Name:
LEUNG, Abraham, C., F.
Address:
United States (US)

2

Name:
ELDON, Michael, A.
Address:
United States (US)

3

Name:
HOCH, Ute
Address:
United States (US)

Priority

Priority Number:
201161551138 P
Priority Date:
25/10/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 45/06; A61K 47/60;

Publication

European Patent Bulletin

1

Issue number:
201832
Publication date:
08/08/2018
Description:
Grant (B1)

2

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1